nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfamethoxazole—ALB—lung cancer	0.197	1	CbGaD
Sulfamethoxazole—UGT1A9—Irinotecan—lung cancer	0.0802	0.174	CbGbCtD
Sulfamethoxazole—ALB—Gefitinib—lung cancer	0.0466	0.101	CbGbCtD
Sulfamethoxazole—ALB—Erlotinib—lung cancer	0.0275	0.0597	CbGbCtD
Sulfamethoxazole—PTGS1—Etoposide—lung cancer	0.0267	0.0578	CbGbCtD
Sulfamethoxazole—CYP2C9—Gefitinib—lung cancer	0.0251	0.0544	CbGbCtD
Sulfamethoxazole—ALB—Irinotecan—lung cancer	0.0249	0.0539	CbGbCtD
Sulfamethoxazole—CYP2C9—Teniposide—lung cancer	0.0243	0.0527	CbGbCtD
Sulfamethoxazole—CYP2C8—Erlotinib—lung cancer	0.0213	0.0461	CbGbCtD
Sulfamethoxazole—CYP2C8—Paclitaxel—lung cancer	0.0195	0.0422	CbGbCtD
Sulfamethoxazole—CYP3A4—Topotecan—lung cancer	0.016	0.0346	CbGbCtD
Sulfamethoxazole—CYP2C8—Etoposide—lung cancer	0.0154	0.0334	CbGbCtD
Sulfamethoxazole—CYP3A4—Gefitinib—lung cancer	0.0146	0.0316	CbGbCtD
Sulfamethoxazole—CYP3A4—Teniposide—lung cancer	0.0142	0.0307	CbGbCtD
Sulfamethoxazole—CYP2C9—Paclitaxel—lung cancer	0.0136	0.0294	CbGbCtD
Sulfamethoxazole—ALB—Methotrexate—lung cancer	0.0132	0.0285	CbGbCtD
Sulfamethoxazole—CYP3A4—Vinorelbine—lung cancer	0.0112	0.0244	CbGbCtD
Sulfamethoxazole—CYP2C9—Cisplatin—lung cancer	0.0109	0.0237	CbGbCtD
Sulfamethoxazole—CYP3A4—Crizotinib—lung cancer	0.00895	0.0194	CbGbCtD
Sulfamethoxazole—CYP3A4—Erlotinib—lung cancer	0.00863	0.0187	CbGbCtD
Sulfamethoxazole—CYP3A4—Paclitaxel—lung cancer	0.0079	0.0171	CbGbCtD
Sulfamethoxazole—CYP3A4—Irinotecan—lung cancer	0.00779	0.0169	CbGbCtD
Sulfamethoxazole—CYP3A4—Vinblastine—lung cancer	0.00693	0.015	CbGbCtD
Sulfamethoxazole—CYP3A4—Etoposide—lung cancer	0.00624	0.0135	CbGbCtD
Sulfamethoxazole—CYP3A4—Docetaxel—lung cancer	0.00571	0.0124	CbGbCtD
Sulfamethoxazole—CYP3A4—Doxorubicin—lung cancer	0.00426	0.00923	CbGbCtD
Sulfamethoxazole—NAT1—respiratory system—lung cancer	0.0034	0.174	CbGeAlD
Sulfamethoxazole—NAT1—bronchus—lung cancer	0.0028	0.143	CbGeAlD
Sulfamethoxazole—NAT1—trachea—lung cancer	0.00251	0.129	CbGeAlD
Sulfamethoxazole—NAT1—bone marrow—lung cancer	0.00199	0.102	CbGeAlD
Sulfamethoxazole—NAT1—lung—lung cancer	0.0018	0.0924	CbGeAlD
Sulfamethoxazole—ALB—mammary gland—lung cancer	0.0014	0.0715	CbGeAlD
Sulfamethoxazole—NAT1—lymph node—lung cancer	0.00123	0.0632	CbGeAlD
Sulfamethoxazole—CYP2C8—mammary gland—lung cancer	0.000982	0.0503	CbGeAlD
Sulfamethoxazole—CYP2C9—mammary gland—lung cancer	0.000872	0.0446	CbGeAlD
Sulfamethoxazole—PTGS1—respiratory system—lung cancer	0.000531	0.0272	CbGeAlD
Sulfamethoxazole—PTGS1—epithelium—lung cancer	0.000443	0.0227	CbGeAlD
Sulfamethoxazole—Sulfaphenazole—CYP2A6—lung cancer	0.000441	0.193	CrCbGaD
Sulfamethoxazole—PTGS1—trachea—lung cancer	0.000392	0.0201	CbGeAlD
Sulfamethoxazole—PTGS1—cardiac atrium—lung cancer	0.000368	0.0189	CbGeAlD
Sulfamethoxazole—Sulfamethazine—ALB—lung cancer	0.000342	0.15	CrCbGaD
Sulfamethoxazole—Sulfadiazine—CYP2E1—lung cancer	0.000342	0.15	CrCbGaD
Sulfamethoxazole—ALB—lymph node—lung cancer	0.000338	0.0173	CbGeAlD
Sulfamethoxazole—Sulfamerazine—ALB—lung cancer	0.000334	0.146	CrCbGaD
Sulfamethoxazole—PTGS1—lung—lung cancer	0.000282	0.0144	CbGeAlD
Sulfamethoxazole—Sulfamethizole—ALB—lung cancer	0.000259	0.113	CrCbGaD
Sulfamethoxazole—Sulfanilamide—CYP2E1—lung cancer	0.000232	0.102	CrCbGaD
Sulfamethoxazole—Dapsone—CYP2E1—lung cancer	0.000207	0.0907	CrCbGaD
Sulfamethoxazole—PTGS1—lymph node—lung cancer	0.000193	0.00986	CbGeAlD
Sulfamethoxazole—Pancreatitis—Methotrexate—lung cancer	0.000131	0.000712	CcSEcCtD
Sulfamethoxazole—Pruritus—Vinorelbine—lung cancer	0.000131	0.000711	CcSEcCtD
Sulfamethoxazole—Mental disorder—Docetaxel—lung cancer	0.00013	0.000707	CcSEcCtD
Sulfamethoxazole—Myalgia—Paclitaxel—lung cancer	0.00013	0.000705	CcSEcCtD
Sulfamethoxazole—Arthralgia—Paclitaxel—lung cancer	0.00013	0.000705	CcSEcCtD
Sulfamethoxazole—Malnutrition—Docetaxel—lung cancer	0.000129	0.000702	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Gemcitabine—lung cancer	0.000129	0.000702	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000129	0.0007	CcSEcCtD
Sulfamethoxazole—Nausea—Topotecan—lung cancer	0.000128	0.000698	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000128	0.000697	CcSEcCtD
Sulfamethoxazole—Fatigue—Gemcitabine—lung cancer	0.000128	0.000696	CcSEcCtD
Sulfamethoxazole—Dapsone—PTGS2—lung cancer	0.000128	0.0559	CrCbGaD
Sulfamethoxazole—Nausea—Erlotinib—lung cancer	0.000127	0.00069	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Methotrexate—lung cancer	0.000127	0.00069	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Etoposide—lung cancer	0.000127	0.000689	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Vinorelbine—lung cancer	0.000126	0.000688	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000126	0.000686	CcSEcCtD
Sulfamethoxazole—Ataxia—Doxorubicin—lung cancer	0.000126	0.000684	CcSEcCtD
Sulfamethoxazole—Neutropenia—Methotrexate—lung cancer	0.000125	0.000679	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Irinotecan—lung cancer	0.000124	0.000678	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Paclitaxel—lung cancer	0.000124	0.000676	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Etoposide—lung cancer	0.000124	0.000675	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Cisplatin—lung cancer	0.000123	0.000671	CcSEcCtD
Sulfamethoxazole—Skin disorder—Etoposide—lung cancer	0.000123	0.00067	CcSEcCtD
Sulfamethoxazole—Dizziness—Vinorelbine—lung cancer	0.000122	0.000665	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Paclitaxel—lung cancer	0.000122	0.000663	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Methotrexate—lung cancer	0.000122	0.000663	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Paclitaxel—lung cancer	0.000122	0.000662	CcSEcCtD
Sulfamethoxazole—Anorexia—Etoposide—lung cancer	0.000121	0.000657	CcSEcCtD
Sulfamethoxazole—Skin disorder—Paclitaxel—lung cancer	0.000121	0.000657	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Irinotecan—lung cancer	0.00012	0.000655	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Irinotecan—lung cancer	0.00012	0.000655	CcSEcCtD
Sulfamethoxazole—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.00012	0.000655	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Cisplatin—lung cancer	0.00012	0.000654	CcSEcCtD
Sulfamethoxazole—Pneumonia—Methotrexate—lung cancer	0.00012	0.000651	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Cisplatin—lung cancer	0.000119	0.00065	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Methotrexate—lung cancer	0.000119	0.000648	CcSEcCtD
Sulfamethoxazole—Infestation—Methotrexate—lung cancer	0.000119	0.000648	CcSEcCtD
Sulfamethoxazole—Depression—Methotrexate—lung cancer	0.000119	0.000646	CcSEcCtD
Sulfamethoxazole—Anorexia—Paclitaxel—lung cancer	0.000118	0.000644	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000118	0.000642	CcSEcCtD
Sulfamethoxazole—Vomiting—Vinorelbine—lung cancer	0.000117	0.000639	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Gemcitabine—lung cancer	0.000117	0.000638	CcSEcCtD
Sulfamethoxazole—Renal failure—Methotrexate—lung cancer	0.000117	0.000637	CcSEcCtD
Sulfamethoxazole—Rash—Vinorelbine—lung cancer	0.000116	0.000634	CcSEcCtD
Sulfamethoxazole—Dermatitis—Vinorelbine—lung cancer	0.000116	0.000633	CcSEcCtD
Sulfamethoxazole—Stomatitis—Methotrexate—lung cancer	0.000116	0.000631	CcSEcCtD
Sulfamethoxazole—Headache—Vinorelbine—lung cancer	0.000116	0.00063	CcSEcCtD
Sulfamethoxazole—Leukopenia—Docetaxel—lung cancer	0.000115	0.000628	CcSEcCtD
Sulfamethoxazole—Eosinophilia—Doxorubicin—lung cancer	0.000114	0.000623	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Doxorubicin—lung cancer	0.000113	0.000617	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000113	0.000616	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Etoposide—lung cancer	0.000113	0.000615	CcSEcCtD
Sulfamethoxazole—Cough—Docetaxel—lung cancer	0.000113	0.000613	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Methotrexate—lung cancer	0.000112	0.000612	CcSEcCtD
Sulfamethoxazole—Insomnia—Paclitaxel—lung cancer	0.000112	0.000611	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Irinotecan—lung cancer	0.000112	0.000611	CcSEcCtD
Sulfamethoxazole—Convulsion—Docetaxel—lung cancer	0.000112	0.000608	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Methotrexate—lung cancer	0.000111	0.000604	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Paclitaxel—lung cancer	0.000111	0.000603	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Etoposide—lung cancer	0.00011	0.000599	CcSEcCtD
Sulfamethoxazole—Myalgia—Docetaxel—lung cancer	0.00011	0.000598	CcSEcCtD
Sulfamethoxazole—Arthralgia—Docetaxel—lung cancer	0.00011	0.000598	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Doxorubicin—lung cancer	0.00011	0.000597	CcSEcCtD
Sulfamethoxazole—Nausea—Vinorelbine—lung cancer	0.00011	0.000597	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Etoposide—lung cancer	0.000109	0.000595	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Paclitaxel—lung cancer	0.000109	0.000595	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Cisplatin—lung cancer	0.000109	0.000595	CcSEcCtD
Sulfamethoxazole—Asthenia—Irinotecan—lung cancer	0.000109	0.000595	CcSEcCtD
Sulfamethoxazole—Fatigue—Etoposide—lung cancer	0.000109	0.000594	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000109	0.000594	CcSEcCtD
Sulfamethoxazole—Neutropenia—Doxorubicin—lung cancer	0.000108	0.000588	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Paclitaxel—lung cancer	0.000108	0.000588	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000107	0.000584	CcSEcCtD
Sulfamethoxazole—Fatigue—Paclitaxel—lung cancer	0.000107	0.000583	CcSEcCtD
Sulfamethoxazole—Hepatitis—Methotrexate—lung cancer	0.000107	0.000581	CcSEcCtD
Sulfamethoxazole—Asthenia—Gemcitabine—lung cancer	0.000106	0.000579	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Methotrexate—lung cancer	0.000105	0.000574	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Doxorubicin—lung cancer	0.000105	0.000574	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Docetaxel—lung cancer	0.000105	0.000573	CcSEcCtD
Sulfamethoxazole—Pruritus—Gemcitabine—lung cancer	0.000105	0.000571	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Methotrexate—lung cancer	0.000105	0.00057	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Irinotecan—lung cancer	0.000104	0.000567	CcSEcCtD
Sulfamethoxazole—Pneumonia—Doxorubicin—lung cancer	0.000104	0.000564	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Etoposide—lung cancer	0.000104	0.000564	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Docetaxel—lung cancer	0.000103	0.000562	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Docetaxel—lung cancer	0.000103	0.000561	CcSEcCtD
Sulfamethoxazole—Infestation—Doxorubicin—lung cancer	0.000103	0.000561	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Doxorubicin—lung cancer	0.000103	0.000561	CcSEcCtD
Sulfamethoxazole—Skin disorder—Docetaxel—lung cancer	0.000102	0.000557	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000102	0.000556	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Cisplatin—lung cancer	0.000102	0.000554	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Paclitaxel—lung cancer	0.000102	0.000553	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Gemcitabine—lung cancer	0.000101	0.000552	CcSEcCtD
Sulfamethoxazole—Renal failure—Doxorubicin—lung cancer	0.000101	0.000551	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Methotrexate—lung cancer	0.000101	0.00055	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Doxorubicin—lung cancer	0.000101	0.00055	CcSEcCtD
Sulfamethoxazole—Dizziness—Irinotecan—lung cancer	0.000101	0.000548	CcSEcCtD
Sulfamethoxazole—Urticaria—Etoposide—lung cancer	0.000101	0.000548	CcSEcCtD
Sulfamethoxazole—Stomatitis—Doxorubicin—lung cancer	0.0001	0.000547	CcSEcCtD
Sulfamethoxazole—Anorexia—Docetaxel—lung cancer	0.0001	0.000546	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Etoposide—lung cancer	0.0001	0.000545	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Etoposide—lung cancer	0.0001	0.000545	CcSEcCtD
Sulfamethoxazole—Eye disorder—Methotrexate—lung cancer	9.98e-05	0.000543	CcSEcCtD
Sulfamethoxazole—Tinnitus—Methotrexate—lung cancer	9.95e-05	0.000542	CcSEcCtD
Sulfamethoxazole—Asthenia—Cisplatin—lung cancer	9.92e-05	0.00054	CcSEcCtD
Sulfamethoxazole—Urticaria—Paclitaxel—lung cancer	9.86e-05	0.000537	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Paclitaxel—lung cancer	9.82e-05	0.000534	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Paclitaxel—lung cancer	9.82e-05	0.000534	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Doxorubicin—lung cancer	9.74e-05	0.00053	CcSEcCtD
Sulfamethoxazole—Vomiting—Irinotecan—lung cancer	9.68e-05	0.000527	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Methotrexate—lung cancer	9.64e-05	0.000525	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Methotrexate—lung cancer	9.62e-05	0.000524	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Doxorubicin—lung cancer	9.61e-05	0.000523	CcSEcCtD
Sulfamethoxazole—Rash—Irinotecan—lung cancer	9.6e-05	0.000523	CcSEcCtD
Sulfamethoxazole—Dermatitis—Irinotecan—lung cancer	9.59e-05	0.000522	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Docetaxel—lung cancer	9.59e-05	0.000522	CcSEcCtD
Sulfamethoxazole—Chills—Methotrexate—lung cancer	9.58e-05	0.000522	CcSEcCtD
Sulfamethoxazole—Headache—Irinotecan—lung cancer	9.54e-05	0.000519	CcSEcCtD
Sulfamethoxazole—Insomnia—Docetaxel—lung cancer	9.52e-05	0.000518	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Cisplatin—lung cancer	9.46e-05	0.000515	CcSEcCtD
Sulfamethoxazole—Vomiting—Gemcitabine—lung cancer	9.43e-05	0.000513	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Docetaxel—lung cancer	9.38e-05	0.000511	CcSEcCtD
Sulfamethoxazole—Mental disorder—Methotrexate—lung cancer	9.35e-05	0.000509	CcSEcCtD
Sulfamethoxazole—Rash—Gemcitabine—lung cancer	9.35e-05	0.000509	CcSEcCtD
Sulfamethoxazole—Dermatitis—Gemcitabine—lung cancer	9.34e-05	0.000509	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Etoposide—lung cancer	9.33e-05	0.000508	CcSEcCtD
Sulfamethoxazole—Malnutrition—Methotrexate—lung cancer	9.29e-05	0.000506	CcSEcCtD
Sulfamethoxazole—Headache—Gemcitabine—lung cancer	9.29e-05	0.000506	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Docetaxel—lung cancer	9.26e-05	0.000504	CcSEcCtD
Sulfamethoxazole—Hepatitis—Doxorubicin—lung cancer	9.24e-05	0.000503	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Docetaxel—lung cancer	9.15e-05	0.000498	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Paclitaxel—lung cancer	9.15e-05	0.000498	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Doxorubicin—lung cancer	9.13e-05	0.000497	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Docetaxel—lung cancer	9.09e-05	0.000495	CcSEcCtD
Sulfamethoxazole—Asthenia—Etoposide—lung cancer	9.09e-05	0.000495	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Doxorubicin—lung cancer	9.08e-05	0.000495	CcSEcCtD
Sulfamethoxazole—Fatigue—Docetaxel—lung cancer	9.07e-05	0.000494	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Doxorubicin—lung cancer	9.06e-05	0.000493	CcSEcCtD
Sulfamethoxazole—Nausea—Irinotecan—lung cancer	9.04e-05	0.000492	CcSEcCtD
Sulfamethoxazole—Pruritus—Etoposide—lung cancer	8.96e-05	0.000488	CcSEcCtD
Sulfamethoxazole—Asthenia—Paclitaxel—lung cancer	8.91e-05	0.000485	CcSEcCtD
Sulfamethoxazole—Nausea—Gemcitabine—lung cancer	8.81e-05	0.00048	CcSEcCtD
Sulfamethoxazole—Vomiting—Cisplatin—lung cancer	8.79e-05	0.000479	CcSEcCtD
Sulfamethoxazole—Pruritus—Paclitaxel—lung cancer	8.78e-05	0.000478	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Doxorubicin—lung cancer	8.74e-05	0.000476	CcSEcCtD
Sulfamethoxazole—Rash—Cisplatin—lung cancer	8.72e-05	0.000475	CcSEcCtD
Sulfamethoxazole—Dermatitis—Cisplatin—lung cancer	8.71e-05	0.000474	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Etoposide—lung cancer	8.66e-05	0.000472	CcSEcCtD
Sulfamethoxazole—Eye disorder—Doxorubicin—lung cancer	8.64e-05	0.00047	CcSEcCtD
Sulfamethoxazole—Tinnitus—Doxorubicin—lung cancer	8.62e-05	0.000469	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Docetaxel—lung cancer	8.61e-05	0.000469	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Paclitaxel—lung cancer	8.5e-05	0.000463	CcSEcCtD
Sulfamethoxazole—Dizziness—Etoposide—lung cancer	8.37e-05	0.000456	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Doxorubicin—lung cancer	8.35e-05	0.000455	CcSEcCtD
Sulfamethoxazole—Vertigo—Methotrexate—lung cancer	8.35e-05	0.000455	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Doxorubicin—lung cancer	8.33e-05	0.000454	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Docetaxel—lung cancer	8.32e-05	0.000453	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Docetaxel—lung cancer	8.32e-05	0.000453	CcSEcCtD
Sulfamethoxazole—Leukopenia—Methotrexate—lung cancer	8.32e-05	0.000453	CcSEcCtD
Sulfamethoxazole—Chills—Doxorubicin—lung cancer	8.3e-05	0.000452	CcSEcCtD
Sulfamethoxazole—Dizziness—Paclitaxel—lung cancer	8.21e-05	0.000447	CcSEcCtD
Sulfamethoxazole—Nausea—Cisplatin—lung cancer	8.21e-05	0.000447	CcSEcCtD
Sulfamethoxazole—Cough—Methotrexate—lung cancer	8.11e-05	0.000442	CcSEcCtD
Sulfamethoxazole—Mental disorder—Doxorubicin—lung cancer	8.1e-05	0.000441	CcSEcCtD
Sulfamethoxazole—Convulsion—Methotrexate—lung cancer	8.05e-05	0.000438	CcSEcCtD
Sulfamethoxazole—Vomiting—Etoposide—lung cancer	8.05e-05	0.000438	CcSEcCtD
Sulfamethoxazole—Malnutrition—Doxorubicin—lung cancer	8.05e-05	0.000438	CcSEcCtD
Sulfamethoxazole—Rash—Etoposide—lung cancer	7.98e-05	0.000435	CcSEcCtD
Sulfamethoxazole—Dermatitis—Etoposide—lung cancer	7.98e-05	0.000434	CcSEcCtD
Sulfamethoxazole—Headache—Etoposide—lung cancer	7.93e-05	0.000432	CcSEcCtD
Sulfamethoxazole—Arthralgia—Methotrexate—lung cancer	7.91e-05	0.000431	CcSEcCtD
Sulfamethoxazole—Myalgia—Methotrexate—lung cancer	7.91e-05	0.000431	CcSEcCtD
Sulfamethoxazole—Tension—Doxorubicin—lung cancer	7.9e-05	0.00043	CcSEcCtD
Sulfamethoxazole—Vomiting—Paclitaxel—lung cancer	7.89e-05	0.00043	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	7.86e-05	0.000428	CcSEcCtD
Sulfamethoxazole—Rash—Paclitaxel—lung cancer	7.83e-05	0.000426	CcSEcCtD
Sulfamethoxazole—Dermatitis—Paclitaxel—lung cancer	7.82e-05	0.000426	CcSEcCtD
Sulfamethoxazole—Nervousness—Doxorubicin—lung cancer	7.82e-05	0.000426	CcSEcCtD
Sulfamethoxazole—Headache—Paclitaxel—lung cancer	7.78e-05	0.000424	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Docetaxel—lung cancer	7.75e-05	0.000422	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Methotrexate—lung cancer	7.59e-05	0.000413	CcSEcCtD
Sulfamethoxazole—Asthenia—Docetaxel—lung cancer	7.55e-05	0.000411	CcSEcCtD
Sulfamethoxazole—Nausea—Etoposide—lung cancer	7.52e-05	0.00041	CcSEcCtD
Sulfamethoxazole—Pruritus—Docetaxel—lung cancer	7.45e-05	0.000405	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Methotrexate—lung cancer	7.44e-05	0.000405	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Methotrexate—lung cancer	7.43e-05	0.000404	CcSEcCtD
Sulfamethoxazole—Nausea—Paclitaxel—lung cancer	7.38e-05	0.000402	CcSEcCtD
Sulfamethoxazole—Skin disorder—Methotrexate—lung cancer	7.37e-05	0.000401	CcSEcCtD
Sulfamethoxazole—Vertigo—Doxorubicin—lung cancer	7.23e-05	0.000394	CcSEcCtD
Sulfamethoxazole—Anorexia—Methotrexate—lung cancer	7.23e-05	0.000394	CcSEcCtD
Sulfamethoxazole—Leukopenia—Doxorubicin—lung cancer	7.2e-05	0.000392	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Docetaxel—lung cancer	7.2e-05	0.000392	CcSEcCtD
Sulfamethoxazole—Cough—Doxorubicin—lung cancer	7.02e-05	0.000382	CcSEcCtD
Sulfamethoxazole—Convulsion—Doxorubicin—lung cancer	6.97e-05	0.00038	CcSEcCtD
Sulfamethoxazole—Dizziness—Docetaxel—lung cancer	6.96e-05	0.000379	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Methotrexate—lung cancer	6.91e-05	0.000376	CcSEcCtD
Sulfamethoxazole—Insomnia—Methotrexate—lung cancer	6.86e-05	0.000374	CcSEcCtD
Sulfamethoxazole—Arthralgia—Doxorubicin—lung cancer	6.85e-05	0.000373	CcSEcCtD
Sulfamethoxazole—Myalgia—Doxorubicin—lung cancer	6.85e-05	0.000373	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	6.8e-05	0.00037	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Methotrexate—lung cancer	6.76e-05	0.000368	CcSEcCtD
Sulfamethoxazole—Vomiting—Docetaxel—lung cancer	6.69e-05	0.000364	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Methotrexate—lung cancer	6.68e-05	0.000364	CcSEcCtD
Sulfamethoxazole—Rash—Docetaxel—lung cancer	6.64e-05	0.000361	CcSEcCtD
Sulfamethoxazole—Dermatitis—Docetaxel—lung cancer	6.63e-05	0.000361	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Methotrexate—lung cancer	6.59e-05	0.000359	CcSEcCtD
Sulfamethoxazole—Headache—Docetaxel—lung cancer	6.59e-05	0.000359	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Doxorubicin—lung cancer	6.57e-05	0.000358	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Methotrexate—lung cancer	6.55e-05	0.000357	CcSEcCtD
Sulfamethoxazole—Fatigue—Methotrexate—lung cancer	6.54e-05	0.000356	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Doxorubicin—lung cancer	6.44e-05	0.000351	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Doxorubicin—lung cancer	6.43e-05	0.00035	CcSEcCtD
Sulfamethoxazole—Skin disorder—Doxorubicin—lung cancer	6.38e-05	0.000347	CcSEcCtD
Sulfamethoxazole—Anorexia—Doxorubicin—lung cancer	6.26e-05	0.000341	CcSEcCtD
Sulfamethoxazole—Nausea—Docetaxel—lung cancer	6.25e-05	0.00034	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Methotrexate—lung cancer	6.2e-05	0.000338	CcSEcCtD
Sulfamethoxazole—Urticaria—Methotrexate—lung cancer	6.03e-05	0.000328	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Methotrexate—lung cancer	6e-05	0.000326	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Methotrexate—lung cancer	6e-05	0.000326	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Doxorubicin—lung cancer	5.98e-05	0.000326	CcSEcCtD
Sulfamethoxazole—Insomnia—Doxorubicin—lung cancer	5.94e-05	0.000323	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Doxorubicin—lung cancer	5.86e-05	0.000319	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Doxorubicin—lung cancer	5.78e-05	0.000315	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Doxorubicin—lung cancer	5.71e-05	0.000311	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Doxorubicin—lung cancer	5.67e-05	0.000309	CcSEcCtD
Sulfamethoxazole—Fatigue—Doxorubicin—lung cancer	5.66e-05	0.000308	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Methotrexate—lung cancer	5.59e-05	0.000304	CcSEcCtD
Sulfamethoxazole—Asthenia—Methotrexate—lung cancer	5.44e-05	0.000296	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Doxorubicin—lung cancer	5.37e-05	0.000292	CcSEcCtD
Sulfamethoxazole—Pruritus—Methotrexate—lung cancer	5.37e-05	0.000292	CcSEcCtD
Sulfamethoxazole—Urticaria—Doxorubicin—lung cancer	5.22e-05	0.000284	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Doxorubicin—lung cancer	5.19e-05	0.000283	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Doxorubicin—lung cancer	5.19e-05	0.000283	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Methotrexate—lung cancer	5.19e-05	0.000283	CcSEcCtD
Sulfamethoxazole—Dizziness—Methotrexate—lung cancer	5.02e-05	0.000273	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Doxorubicin—lung cancer	4.84e-05	0.000263	CcSEcCtD
Sulfamethoxazole—Vomiting—Methotrexate—lung cancer	4.82e-05	0.000263	CcSEcCtD
Sulfamethoxazole—Rash—Methotrexate—lung cancer	4.78e-05	0.00026	CcSEcCtD
Sulfamethoxazole—Dermatitis—Methotrexate—lung cancer	4.78e-05	0.00026	CcSEcCtD
Sulfamethoxazole—Headache—Methotrexate—lung cancer	4.75e-05	0.000259	CcSEcCtD
Sulfamethoxazole—Asthenia—Doxorubicin—lung cancer	4.71e-05	0.000257	CcSEcCtD
Sulfamethoxazole—Pruritus—Doxorubicin—lung cancer	4.65e-05	0.000253	CcSEcCtD
Sulfamethoxazole—Nausea—Methotrexate—lung cancer	4.51e-05	0.000245	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Doxorubicin—lung cancer	4.49e-05	0.000245	CcSEcCtD
Sulfamethoxazole—Dizziness—Doxorubicin—lung cancer	4.34e-05	0.000236	CcSEcCtD
Sulfamethoxazole—Vomiting—Doxorubicin—lung cancer	4.18e-05	0.000227	CcSEcCtD
Sulfamethoxazole—Rash—Doxorubicin—lung cancer	4.14e-05	0.000225	CcSEcCtD
Sulfamethoxazole—Dermatitis—Doxorubicin—lung cancer	4.14e-05	0.000225	CcSEcCtD
Sulfamethoxazole—Headache—Doxorubicin—lung cancer	4.11e-05	0.000224	CcSEcCtD
Sulfamethoxazole—Nausea—Doxorubicin—lung cancer	3.9e-05	0.000212	CcSEcCtD
Sulfamethoxazole—CYP2C9—Metabolism—B4GALT5—lung cancer	1.15e-05	8.43e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PIK3CG—lung cancer	1.15e-05	8.42e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—STK11—lung cancer	1.15e-05	8.42e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.14e-05	8.4e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—HSD17B10—lung cancer	1.14e-05	8.39e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CYP1A1—lung cancer	1.13e-05	8.32e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—EGF—lung cancer	1.13e-05	8.32e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—ERCC2—lung cancer	1.12e-05	8.26e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GSTA4—lung cancer	1.11e-05	8.2e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ALDOA—lung cancer	1.1e-05	8.08e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ALDOA—lung cancer	1.09e-05	8.04e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.09e-05	8.01e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GSTA2—lung cancer	1.09e-05	7.99e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—APOA1—lung cancer	1.09e-05	7.98e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.08e-05	7.9e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—NCOA3—lung cancer	1.07e-05	7.85e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—CREBBP—lung cancer	1.06e-05	7.81e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—NCOA3—lung cancer	1.06e-05	7.8e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CKB—lung cancer	1.06e-05	7.8e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—GSTP1—lung cancer	1.06e-05	7.79e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.05e-05	7.71e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GSTA1—lung cancer	1.05e-05	7.71e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.04e-05	7.67e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ABCG2—lung cancer	1.04e-05	7.63e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ADCY1—lung cancer	1.04e-05	7.63e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—PIK3CA—lung cancer	1.04e-05	7.63e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ABCC3—lung cancer	1.04e-05	7.62e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ADCY1—lung cancer	1.03e-05	7.59e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ABCG2—lung cancer	1.03e-05	7.59e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CAT—lung cancer	1.03e-05	7.58e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.03e-05	7.54e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—HPGDS—lung cancer	1.02e-05	7.48e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ENO2—lung cancer	1.02e-05	7.48e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—HPGDS—lung cancer	1.01e-05	7.44e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ENO2—lung cancer	1.01e-05	7.44e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PPP2R1B—lung cancer	1.01e-05	7.44e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PIK3CD—lung cancer	1.01e-05	7.4e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PPP2R1B—lung cancer	1.01e-05	7.4e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—AKR1C1—lung cancer	1e-05	7.38e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—ABCB1—lung cancer	1e-05	7.37e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—POMC—lung cancer	9.98e-06	7.34e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CNDP2—lung cancer	9.97e-06	7.33e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTM2—lung cancer	9.97e-06	7.33e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—POMC—lung cancer	9.93e-06	7.3e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GSTT1—lung cancer	9.88e-06	7.26e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—TYMS—lung cancer	9.85e-06	7.24e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GSTT1—lung cancer	9.82e-06	7.22e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP2A6—lung cancer	9.76e-06	7.18e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GCLC—lung cancer	9.76e-06	7.18e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—UGT1A1—lung cancer	9.75e-06	7.16e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—GSTM1—lung cancer	9.74e-06	7.16e-05	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—AKT1—lung cancer	9.73e-06	7.15e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	9.72e-06	7.15e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—APOA1—lung cancer	9.72e-06	7.14e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GCLC—lung cancer	9.71e-06	7.13e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP2A6—lung cancer	9.71e-06	7.13e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—MTMR3—lung cancer	9.7e-06	7.13e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	9.67e-06	7.11e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PGAM1—lung cancer	9.46e-06	6.95e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GNG11—lung cancer	9.4e-06	6.91e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	9.35e-06	6.87e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	9.3e-06	6.84e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ENO1—lung cancer	9.25e-06	6.8e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CYP1A1—lung cancer	9.23e-06	6.79e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	9.22e-06	6.78e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ENO1—lung cancer	9.2e-06	6.76e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—CREBBP—lung cancer	9.19e-06	6.76e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	9.17e-06	6.74e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—ERCC2—lung cancer	9.16e-06	6.73e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—ALB—lung cancer	9.1e-06	6.69e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP2A7—lung cancer	9.02e-06	6.63e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—RAF1—lung cancer	8.99e-06	6.61e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ALDOA—lung cancer	8.95e-06	6.58e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PIK3CG—lung cancer	8.87e-06	6.52e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SDC4—lung cancer	8.83e-06	6.49e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PIK3CB—lung cancer	8.78e-06	6.45e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—NCOA3—lung cancer	8.69e-06	6.39e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	8.54e-06	6.27e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—AKT1—lung cancer	8.48e-06	6.23e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ABCG2—lung cancer	8.45e-06	6.21e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ADCY1—lung cancer	8.45e-06	6.21e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—POMC—lung cancer	8.44e-06	6.21e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP2E1—lung cancer	8.3e-06	6.1e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ENO2—lung cancer	8.29e-06	6.09e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—HPGDS—lung cancer	8.29e-06	6.09e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP2E1—lung cancer	8.25e-06	6.07e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PPP2R1B—lung cancer	8.23e-06	6.05e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CREBBP—lung cancer	8.22e-06	6.05e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—NQO1—lung cancer	8.21e-06	6.03e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—NQO1—lung cancer	8.16e-06	6e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	8.12e-06	5.97e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—IL2—lung cancer	8.06e-06	5.93e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—RRM1—lung cancer	8.04e-06	5.91e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTA3—lung cancer	8.04e-06	5.91e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GSTT1—lung cancer	8.04e-06	5.91e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	8.04e-06	5.91e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	7.99e-06	5.87e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	7.96e-06	5.85e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GCLC—lung cancer	7.94e-06	5.84e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP2A6—lung cancer	7.94e-06	5.84e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—APOA1—lung cancer	7.92e-06	5.82e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	7.92e-06	5.82e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	7.91e-06	5.82e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PIK3CD—lung cancer	7.8e-06	5.73e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—RAF1—lung cancer	7.78e-06	5.72e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—ALB—lung cancer	7.7e-06	5.66e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	7.58e-06	5.58e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—B4GALT5—lung cancer	7.56e-06	5.56e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ENO1—lung cancer	7.53e-06	5.54e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	7.5e-06	5.52e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	7.41e-06	5.45e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—STK11—lung cancer	7.4e-06	5.44e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—STK11—lung cancer	7.36e-06	5.41e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTA4—lung cancer	7.35e-06	5.41e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—EP300—lung cancer	7.23e-06	5.32e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PIK3CG—lung cancer	7.23e-06	5.32e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTA2—lung cancer	7.17e-06	5.27e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—SRC—lung cancer	7.03e-06	5.17e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	6.94e-06	5.1e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTA1—lung cancer	6.91e-06	5.08e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	6.9e-06	5.08e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—POMC—lung cancer	6.88e-06	5.06e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—VEGFA—lung cancer	6.85e-06	5.04e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GSTP1—lung cancer	6.85e-06	5.03e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ABCC3—lung cancer	6.84e-06	5.03e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GSTP1—lung cancer	6.81e-06	5e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PIK3CB—lung cancer	6.8e-06	5e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—NRAS—lung cancer	6.77e-06	4.97e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP2E1—lung cancer	6.76e-06	4.97e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PTGS2—lung cancer	6.73e-06	4.95e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CREBBP—lung cancer	6.7e-06	4.93e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—NQO1—lung cancer	6.68e-06	4.91e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CAT—lung cancer	6.66e-06	4.9e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CAT—lung cancer	6.62e-06	4.87e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	6.62e-06	4.87e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—AKR1C1—lung cancer	6.62e-06	4.87e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	6.58e-06	4.84e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	6.54e-06	4.81e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	6.48e-06	4.76e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—MAPK3—lung cancer	6.48e-06	4.76e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ABCB1—lung cancer	6.48e-06	4.76e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ABCB1—lung cancer	6.44e-06	4.74e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—UGT1A1—lung cancer	6.43e-06	4.72e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—TYMS—lung cancer	6.36e-06	4.68e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PIK3CD—lung cancer	6.36e-06	4.67e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—TYMS—lung cancer	6.33e-06	4.65e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GSTM1—lung cancer	6.29e-06	4.62e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—ALB—lung cancer	6.28e-06	4.61e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GSTM1—lung cancer	6.25e-06	4.6e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GNG11—lung cancer	6.2e-06	4.56e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—STK11—lung cancer	6.02e-06	4.43e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP1A1—lung cancer	5.96e-06	4.38e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP1A1—lung cancer	5.93e-06	4.36e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ERCC2—lung cancer	5.91e-06	4.35e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ALDOA—lung cancer	5.9e-06	4.34e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ERCC2—lung cancer	5.88e-06	4.32e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PTEN—lung cancer	5.87e-06	4.32e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—KRAS—lung cancer	5.82e-06	4.28e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—NCOA3—lung cancer	5.73e-06	4.21e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	5.65e-06	4.15e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—EP300—lung cancer	5.6e-06	4.12e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ADCY1—lung cancer	5.57e-06	4.1e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ABCG2—lung cancer	5.57e-06	4.1e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GSTP1—lung cancer	5.57e-06	4.1e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PIK3CB—lung cancer	5.54e-06	4.07e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PTGS2—lung cancer	5.49e-06	4.04e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ENO2—lung cancer	5.47e-06	4.02e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—HPGDS—lung cancer	5.47e-06	4.02e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PPP2R1B—lung cancer	5.43e-06	3.99e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CAT—lung cancer	5.42e-06	3.99e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.39e-06	3.96e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PIK3CA—lung cancer	5.35e-06	3.93e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTT1—lung cancer	5.3e-06	3.9e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ABCB1—lung cancer	5.27e-06	3.88e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP2A6—lung cancer	5.24e-06	3.85e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GCLC—lung cancer	5.24e-06	3.85e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—TYMS—lung cancer	5.18e-06	3.81e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—TP53—lung cancer	5.18e-06	3.81e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GSTM1—lung cancer	5.12e-06	3.76e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—APOA1—lung cancer	5.12e-06	3.76e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—APOA1—lung cancer	5.09e-06	3.74e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ENO1—lung cancer	4.97e-06	3.65e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—HRAS—lung cancer	4.95e-06	3.64e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.9e-06	3.6e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.87e-06	3.58e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP1A1—lung cancer	4.85e-06	3.57e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ERCC2—lung cancer	4.81e-06	3.54e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PTEN—lung cancer	4.79e-06	3.52e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PIK3CG—lung cancer	4.67e-06	3.43e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PIK3CG—lung cancer	4.64e-06	3.41e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—EP300—lung cancer	4.57e-06	3.36e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP2E1—lung cancer	4.46e-06	3.27e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—POMC—lung cancer	4.45e-06	3.27e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—POMC—lung cancer	4.42e-06	3.25e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—NQO1—lung cancer	4.41e-06	3.24e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—AKT1—lung cancer	4.37e-06	3.21e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CREBBP—lung cancer	4.33e-06	3.18e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CREBBP—lung cancer	4.31e-06	3.17e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—APOA1—lung cancer	4.16e-06	3.06e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PIK3CA—lung cancer	4.14e-06	3.05e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PIK3CD—lung cancer	4.11e-06	3.02e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PIK3CD—lung cancer	4.08e-06	3e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ALB—lung cancer	4.05e-06	2.98e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.99e-06	2.93e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—STK11—lung cancer	3.97e-06	2.92e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PIK3CG—lung cancer	3.8e-06	2.79e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTP1—lung cancer	3.67e-06	2.7e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—POMC—lung cancer	3.62e-06	2.66e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PIK3CB—lung cancer	3.58e-06	2.63e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CAT—lung cancer	3.58e-06	2.63e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PIK3CB—lung cancer	3.56e-06	2.62e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PTGS2—lung cancer	3.55e-06	2.61e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PTGS2—lung cancer	3.53e-06	2.59e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CREBBP—lung cancer	3.52e-06	2.59e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ABCB1—lung cancer	3.48e-06	2.56e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—TYMS—lung cancer	3.42e-06	2.51e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—AKT1—lung cancer	3.38e-06	2.49e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PIK3CA—lung cancer	3.38e-06	2.48e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTM1—lung cancer	3.38e-06	2.48e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PIK3CD—lung cancer	3.34e-06	2.46e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ALB—lung cancer	3.3e-06	2.43e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP1A1—lung cancer	3.2e-06	2.35e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ERCC2—lung cancer	3.17e-06	2.33e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PTEN—lung cancer	3.09e-06	2.27e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PTEN—lung cancer	3.08e-06	2.26e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—EP300—lung cancer	2.95e-06	2.17e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—EP300—lung cancer	2.93e-06	2.16e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PIK3CB—lung cancer	2.91e-06	2.14e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PTGS2—lung cancer	2.89e-06	2.12e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—AKT1—lung cancer	2.76e-06	2.03e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—APOA1—lung cancer	2.75e-06	2.02e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PTEN—lung cancer	2.52e-06	1.85e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PIK3CG—lung cancer	2.51e-06	1.84e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—EP300—lung cancer	2.4e-06	1.76e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—POMC—lung cancer	2.39e-06	1.75e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CREBBP—lung cancer	2.32e-06	1.71e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PIK3CD—lung cancer	2.2e-06	1.62e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PIK3CA—lung cancer	2.18e-06	1.6e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ALB—lung cancer	2.18e-06	1.6e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PIK3CA—lung cancer	2.17e-06	1.59e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PIK3CB—lung cancer	1.92e-06	1.41e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PTGS2—lung cancer	1.9e-06	1.4e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—AKT1—lung cancer	1.78e-06	1.31e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PIK3CA—lung cancer	1.78e-06	1.31e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—AKT1—lung cancer	1.77e-06	1.3e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PTEN—lung cancer	1.66e-06	1.22e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—EP300—lung cancer	1.58e-06	1.16e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—AKT1—lung cancer	1.45e-06	1.07e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PIK3CA—lung cancer	1.17e-06	8.61e-06	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—AKT1—lung cancer	9.57e-07	7.03e-06	CbGpPWpGaD
